ENTITY
SK Bioscience

SK Bioscience (302440 KS)

146
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
Refresh
27 Mar 2024 12:04

KRX Short Interest Weekly (Mar 22nd): Samsung SDI, Rainbow Robotics, Jyp Entertainment

We analyzed KRX short interest report for the past week and highlighted short interest changes in Samsung SDI, Rainbow Robotics, Jyp Entertainment.

Logo
224 Views
Share
bullishSK Bioscience
28 Oct 2023 18:09

SK Bioscience (302440 KS): Significantly Improved 3Q Result Benefitted From One-Time Payment

In 3Q23, revenue jumped 2.5x YoY and 12.1x QoQ to KRW232B, mainly due to the inflow related to Novavax vaccine contract settlement, resumption of...

Logo
450 Views
Share
bullishSK Bioscience
14 Sep 2023 19:42

SK Bioscience (302440 KS): Flu Vaccine Output Resumes; Next-Gen Typhoid Vaccine Is On Card

SK Bioscience began first shipment of flu vaccine, SKYCellflu for 2023–24 flu season after a gap of three years. The company has entered agreement...

Logo
410 Views
Share
bullishSK Bioscience
27 Nov 2021 06:44

The Highly Mutated Omicron COVID Variant - Onset of the Dark Winter?

There has been a new, highly mutated COVID variant found in South Africa named Omicron by the WHO. In this insight, we will provide further details...

Logo
514 Views
Share
bullishSK Bioscience
13 Jun 2023 18:37

SK Bioscience (302440 KS): Core Vaccines Gaining Traction; COVID Vaccine Gets International Approval

SK Bioscience recorded 5% YoY growth in core vaccine revenue in 1Q23, driven by shingles vaccine, SKY Zoster. Last month, the company received...

Logo
276 Views
Share
x